January 11, 2022
NEWARK, Calif. -- Triple Ring Technologies and Woods Hole Oceanographic Institution (WHOI) are collaborating to fill an unmet need in environmental sensing – providing a fieldable, portable microplastic sensor that quantifies the number of plastic particles in water. A comprehensive understanding of microplastic pollution is significantly hampered by the unavailability of low-cost, robust, accurate, and [...]
Arch Pharmalabs Ties up with Orochem Technologies Inc., USA
January 10, 2022
Mumbai, Maharashtra, India Arch Pharmalabs Ltd., India, announced the signing of a Technology Access & Services Agreement with Orochem Technologies Inc., USA, on an exclusive basis. The Agreement allows Arch to collaborate with Orochem for using Orochem’s proprietary Simulated Moving Bed (SMB) platform for Pharmaceutical and other applications. Simulated Moving Bed (SMB) technology is a [...]
Organovo Files Counterclaims In Patent Lawsuit Brought Against It by CellInk
January 10, 2022
SAN DIEGO -- Organovo Holdings, Inc. (Nasdaq: ONVO), today released its first detailed response to the lawsuit Cellink (NASDAQ Stockholm: BICO) filed against it in Delaware court in 2021. At issue in this lawsuit is whether Cellink is infringing Organovo patents. Organovo, as one of the earliest and most prominent 3D bioprinting companies, has built [...]
Wasatch Photonics and Nikalyte Partner to Advance Application of SERS
January 10, 2022
Morrisville, N.C. – Wasatch Photonics and Nikalyte Ltd. are pleased to announce a partnership to facilitate evaluation and testing of a novel SERS substrate for trace detection of materials, with applications in narcotics, food safety, pharmaceuticals, environmental, and biological analysis. Surface Enhanced Raman Spectroscopy (SERS) is a specialized form of Raman spectroscopy in which the [...]
BGI and Gencove Extend Agreement to Offer Low-Pass Whole Genome Sequencing and Analysis …
January 10, 2022
New York and Cambridge, MA -- Gencove, a pioneer of low-pass whole genome sequencing (LPWGS) analysis, and BGI Americas Corporation, US subsidiary of BGI Genomics Co. Ltd. (300676.SZ), one of the world's leading multi-omics companies, today announced the extension of the subscription and joint marketing agreements. The partnership combines BGI’s sequencing services from proprietary DNBSEQ™ [...]
January 10, 2022
Pfizer and Codex DNA agree to strategic, multiyear, early access research collaboration, leveraging Codex DNA’s novel enzymatic DNA synthesis (EDS) technology Pfizer’s successful development and commercialization of licensed products could result in milestone payments in excess of $100 million SAN DIEGO -- Codex DNA, Inc. (NASDAQ: DNAY), a leader in the development of automated solutions [...]
January 10, 2022
NASHVILLE, Tenn. -- Today, Nashville Biosciences, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC), announced an agreement with Illumina, a leading genomic technology company, to realize the full potential of VUMC’s DNA databank, BioVU®. The agreement is a continuation of Vanderbilt’s long-term effort around BioVU and will accelerate genomic sequencing, resulting in new discoveries to advance [...]
Agilent Expands Manufacturing Capacity in Shanghai
January 10, 2022
Investment Will Help Meet Growing Demand for Agilent’s Products in China SANTA CLARA, Calif. -- Agilent Technologies (NYSE: A) today announced plans to invest $20 million to expand its Shanghai manufacturing center to meet growing demand in China for the company’s advanced liquid chromatography (LC), spectrometer and mass spectroscopy (MS) systems. “This expansion will [...]
Illumina Partners with Agendia to Expand Genomic Testing in Breast Cancer Care
January 10, 2022
Multi-year partnership to advance the use of next-generation sequencing for decentralized oncology testing and to bring improved insights to patients with breast cancer globally SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) today announced a multi-year partnership with Agendia N.V., a world leader in precision oncology for breast cancer, to co-develop in vitro diagnostic (IVD) tests for [...]
Illumina collaborates with Nashville Biosciences to accelerate medicines development
January 10, 2022
Collaboration will transform new insights into drug discovery and therapy development through large-scale genomics SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced a multi-year agreement to accelerate medicines development through large-scale genomics and the establishment of a preeminent clinico-genomic resource. Using [...]

